Delivery Order SPE2DB22D3501-SPE2DB24FUQ72
- Not listed
- This federal contract award, valued at $1,102.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MESALAMINE DR 400 MG CAPSULE 180S, a pharmaceutical product, to support federal healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,192.91 firm fixed-price contract is for the delivery of 180 capsules of MESALAMINE DR 400 MG. The contract has an ultimate completion date of May 22, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MESALAMINE DR 400 MG CAPSULE 180S, a pharmaceutical product, with a ceiling value of $2,245.96. The contract is a Firm Fixed Price arrangement with a period of performance through July 10, 2025. Amerisourcebergen Drug Corp is the prime contractor and this award is not associated with...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,398.31, is for the delivery of MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is April 2, 2025. This award is not designated as a set-aside contract. Amerisourcebergen holds a...
- This is a $1,394.90 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency. The contract is for the supply of MESALAMINE DR 400 MG CAPSULE 180S, a medication used to treat gastrointestinal conditions. The contract has an ultimate completion date of May 19, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of pharmaceutical products, including Mesalamine DR 400 mg capsules. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $4,272.71 and a completion date of July 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,059,712 units of the medication Mesalamine DR 400 mg capsule in 180-count bottles. The delivery order, valued at $15,721.70, has a firm fixed-price pricing type and an ultimate completion date of April 29, 2025. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,232.80 firm fixed-price delivery order covers the procurement of 4,567,343,614 units of Mesalamine DR 400 mg capsules. The contract has an ultimate completion date of February 24, 2025 and was awarded on February 21, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award to AmerisourceBergen Drug Corp is a delivery order valued at $1,484.41 for the supply of MESALAMINE ER 0.375 GRAM CAP 120S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 28, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, with no major subcontractors...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,881.63 firm fixed-price contract is for the delivery of MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product. The contract has a completion date of March 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUQ72Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,991.84, is for the delivery of MESALAMINE DR 400 MG CAPSULE 180S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a performance period running through February 21, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. No set-aside designation was used for this specific award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 2/20/24 |